Patients with prostate cancer should be enrolled in a national, controlled trial

doi:10.1136/bmj.318.7176.126

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

R G Willis, Consultant urologist

Carlisle Hospitals NHS Trust, Cumberland Infirmary, Carlisle CA2 7HY

EDITOR—I endorse the views of Mulley and Barry on treating prostate cancer.1 British urologists are deluged with data from the United States which encourages radical prostatectomy, yet there is no good evidence from randomised controlled trials to validate their policy.

If the editorial had been written by an American urologist the conclusion would have been entirely different. Mulley and Barry failed to emphasise the powerful financial motives behind much of what is published about prostate cancer in the …